Back
Aprea Therapeutics Vs. Ingevity Industry Stock Comparison
Sell
30
APRE
Aprea Therapeutics
Last Price:
2.60
Seasonality Move:
-39.53%
Sell
15
NGVT
Ingevity
Last Price:
37.03
Seasonality Move:
10.62%
Sell
30
Aprea Therapeutics (APRE)
is a Sell
Is Aprea Therapeutics a Buy, Sell or Hold?
- The current Aprea Therapeutics [APRE] share price is $2.60. The Score for APRE is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- APRE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
15
Ingevity (NGVT)
is a Sell
Is Ingevity a Buy, Sell or Hold?
- The current Ingevity [NGVT] share price is $37.04. The Score for NGVT is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
- NGVT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
APRE Stock Price Chart
What is Aprea Therapeutics's stock price today?
-
The Aprea Therapeutics share price today is $2.60
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APRE is experiencing selling pressure, which indicates risk of future bearish movement.
APRE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.21 | Sell |
| Relative Strength Index (14 RSI): | 33.15 | Sell |
| Chaikin Money Flow: | -13903 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.78 - 3.32) | Sell |
| Bollinger Bands (100): | (3.14 - 4.58) | Sell |
NGVT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.3 | Sell |
| Relative Strength Index (14 RSI): | 47.28 | Sell |
| Chaikin Money Flow: | 509201 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.32 - 40.1) | Sell |
| Bollinger Bands (100): | (36.91 - 47.49) | Sell |
APRE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.73 | Sell |
| 20-day SMA: | 2.96 | Sell |
| 50-day SMA: | 3.31 | Sell |
| 200-day SMA: | 4.86 | Sell |
| 8-day EMA: | 2.74 | Sell |
| 20-day EMA: | 2.94 | Sell |
| 50-day EMA: | 3.3 | Sell |
| 200-day EMA: | 4.5 | Sell |
NGVT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.05 | Sell |
| 20-day SMA: | 37.78 | Sell |
| 50-day SMA: | 38.09 | Sell |
| 200-day SMA: | 44.29 | Sell |
| 8-day EMA: | 37.4 | Sell |
| 20-day EMA: | 37.93 | Sell |
| 50-day EMA: | 38.95 | Sell |
| 200-day EMA: | 43.92 | Sell |
Aprea Therapeutics Earnings Growth & APRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.69 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.21 per share, and an increase next year of $2.56 per share.
Ingevity Earnings Growth & NGVT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.69 per share, and an increase next year of $1.18 per share.
Aprea Therapeutics Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ingevity Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||